NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) today announced the findings of a retrospective study published in the Journal of Clinical Monitoring and Computing in which Dr. Ayten ...
"Patients on chemotherapy should not ignore symptoms like fatigue, thinking it's just related to the chemotherapy. The treating physician should be made aware of these symptoms, as this could lead to ...
An expert discussed the findings of the COMMANDS trial evaluating Reblozyl’s role in red blood cell transfusion independence for patients with MDS. Reblozyl (luspatercept) has become the new standard ...
A National Institutes of Health-supported study found that the type of transfusion approach used to support adults who developed anemia after a heart attack did not make a significant difference in ...
An international panel of experts co-chaired by Jeffrey Carson, Distinguished Professor of Medicine at Rutgers Robert Wood Johnson Medical School, developed guidelines for new strategies which could ...
An expert explained the burden that red blood cell transfusions can place on patients with MDS. Among patients with myelodysplastic syndromes (MDS), treatment with Reblozyl (luspatercept) resulted in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results